BOPO — Biopower Operations Share Price
Last trade - 00:00- $17.40m
- $20.80m
- $0.18m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 46.4 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -63.39% | ||
Financial Summary
| Year End 30th Nov | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 0.01 | n/a | n/a | 0.17 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BioPower Operations Corporation is a shell company. The Company has entered into an Asset Purchase Agreement (the APA) with Rafael Ben Shaya, Troy MacDonald, Adam Benchaya, Thomas Perez, Tom Saban and Edouard Pouchoy. The Company has not generated any revenue from business operations.
Directors
- Last Annual
- November 30th, 2021
- Last Interim
- February 28th, 2022
- Incorporated
- January 5th, 2011
- Public Since
- February 13th, 2012
- No. of Employees
- 4
- Sector
- Renewable Energy
- Industry
- Energy
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 45,625,000
- Address
- Suite 301, 5379 Lyons Rd., COCONUT CREEK, 33073
- Web
- http://biopowercorp.com/
- Phone
- +1 9545099830
- Auditors
- BF Borgers CPA PC
Similar to BOPO
ABCO Energy
Pink Sheets on Nasdaq
Ace Ethanol LLC
Pink Sheets on Nasdaq
Adkins Energy LLC
Pink Sheets on Nasdaq
Advanced Bioenergy LLC
Pink Sheets on Nasdaq
Alternative Energy Development
Pink Sheets on Nasdaq
FAQ
As of Today at 13:03 UTC, shares in Biopower Operations are trading at $0.38. This share price information is delayed by 15 minutes.
Shares in Biopower Operations last closed at $0.38 and the price had moved by +440.94% over the past 365 days. In terms of relative price strength the Biopower Operations share price has outperformed the S&P500 Index by +559.98% over the past year.
There is no consensus recommendation for this security.
Biopower Operations does not currently pay a dividend.
Biopower Operations does not currently pay a dividend.
Biopower Operations does not currently pay a dividend.
To buy shares in Biopower Operations you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.38, shares in Biopower Operations had a market capitalisation of $17.40m.
Here are the trading details for Biopower Operations:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: BOPO
Based on an overall assessment of its quality, value and momentum Biopower Operations is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biopower Operations. Over the past six months, its share price has outperformed the S&P500 Index by +67.28%.
As of the last closing price of $0.38, shares in Biopower Operations were trading -5.98% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Biopower Operations PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Biopower Operations' management team is headed by:
- Troy Macdonald - CHM
- Adam Benchaya - PRE
- Robert Kohn - CFO
- Thomas Perez - DRC